| Titolo | Pubblicato in | Anno |
|---|---|---|
| Immune checkpoint inhibitors and pre-existing antinuclear antibodies: the rheumatologist point of view | CLINICAL & TRANSLATIONAL ONCOLOGY | 2021 |
| The role of soluble LAG3 and soluble immune checkpoints profile in advanced head and neck cancer: a pilot study | JOURNAL OF PERSONALIZED MEDICINE | 2021 |
| Anti–PD-1 and Anti–PD-L1 in head and neck cancer: a network meta-analysis | FRONTIERS IN IMMUNOLOGY | 2021 |
| The impact of locoregional treatment on response to Nivolumab in advanced platinum refractory head and neck cancer: the NEED TRIAL | VACCINES | 2020 |
| The agnostic role of site of metastasis in predicting outcomes in cancer patients treated with immunotherapy | VACCINES | 2020 |
| Induction chemotherapy in nonlaryngeal human papilloma virus-negative high-risk head and neck cancer: a real-world experience | ANTI-CANCER DRUGS | 2020 |
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma
